title: Guiding effective decisions: an interview with Matthew Segall, CEO of Optibrium. Interview by Wendy A. Warr.
authors.forename: Matthew
authors.initials: M
authors.lastname: Segall
mesh_terms: D019295:Computational Biology / Q000639:trends; D003577:Cytochrome P-450 Enzyme System / Q000494:pharmacology*; D003661:Decision Support Techniques; D015195:Drug Design; D055808:Drug Discovery / Q000295:instrumentation* / Q000379:methods; D005544:Forecasting; D012984:Software / Q000639:trends*
chemical_list: D003577:Cytochrome P-450 Enzyme System